Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Orgenesis Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 34 | 28 | −6 |
| Shares | 3.51M | 3.14M | −371.6K (−10.6%) |
| Value | $17.8M | $15.5M | −$2.26M (−12.7%) |
New holders (1)
Institutions that held Orgenesis Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 33,601 | $166.0K | 0.00% |
Sold out (7)
Institutions that held Orgenesis Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| SG Americas Securities, LLC | 63,992 | $324.0K |
| Tibra Equities Europe Ltd | 64,000 | $324.0K |
| Trexquant Investment LP | 21,015 | $107.0K |
| Goldman Sachs Group Inc | 19,638 | $100.0K |
| Royal Bank of Canada | 5,677 | $29.0K |
| New York State Common Retirement Fund | 170 | $1.00K |
| O'Shaughnessy Asset Management, LLC | 62 | $0 |